Aim & Scope
This widely respected journal presents the latest laboratory and clinical studies on biological receptors and associated signal transduction pathways for ligands involved in the regulation of central and peripheral tissues and cells, including the immune system, thus covering the field from neurotransmitters to peptides, steroids, growth factors, cytokines and drugs. The Journal of Receptors and Signal Transduction rapidly communicates important research results to the international scientific community in a variety of stimulating formats, including original and review papers, brief communications, solicited and unsolicited mini reviews, and symposia proceedings. The Journal of Receptors and Signal Transduction maintains a rigorous peer-review process that ensures the originality, timeliness, and significance of topics covered, such as: Pharmacology of receptors and channels; Physicochemical and biophysical properties; Modeling; Molecular biology and genetics; Structure and function of receptors and channels; Signal transduction pathways; Pathology of receptors and channels; Molecular strategies for designing drugs acting on receptors; Receptors in the diagnosis and therapy of disease. [1]
Continuations / Journal History
| ( 1995 - 2001 ) | Journal of Receptors and Signal Transduction Research | ( 2002 - 9999 ) | Journal of Receptors and Signal Transduction |
2024 - VOLUME 44, ISSUE 1
cGAS-STING and PD1/PDL-1 pathway in breast cancer: a window to new therapies.
Journal of Receptors and Signal Transduction , 2024 - VOLUME 44, ISSUE 1 , pp 1-7.
A Chauhan , J Singh , N Sangwan , PK Avti
Journal of Receptors and Signal Transduction , 2024 - VOLUME 44, ISSUE 1 , pp 8-18.
Z Sahin , O Aktas , OF Kalkan , ... , S Kutlu
Journal of Receptors and Signal Transduction , 2024 - VOLUME 44, ISSUE 1 , pp 19-26.
X Zou , M Wu , M Tu , ... , M Li
Journal of Receptors and Signal Transduction , 2024 - VOLUME 44, ISSUE 1 , pp 27-34.
NMS Mahmood , AM Mahmud , IM Maulood
Journal of Receptors and Signal Transduction , 2024 - VOLUME 44, ISSUE 1 , pp 35-40.
Editorial Retractions, Expressions of Concern and External Notices
LATS2 promotes cardiomyocyte H9C2 cells apoptosis via the Prx3-Mfn2-mitophagy pathways.
Y Tian , W Lv , C Lu , ... , H Song
Journal of Receptors and Signal Transduction2019 - VOLUME 39, ISSUES 5-6 pp 470-478.
12 101
NURR1 inhibition reduces hypoxia-mediated cardiomyocyte necrosis via blocking Mst1-JNK-mPTP pathway.
Journal of Receptors and Signal Transduction2019 - VOLUME 39, ISSUE 4 pp 350-358.
7 93